Thyroid Cancer | Tumor

CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.

Six Survivors Share Their Thyroid Cancer Stories

February 25th 2016, 1:21pm

Article

Danielle Nicosia on Being Misdiagnosed

January 25th 2016, 10:09pm

Video

Danielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.

Building on the Success of Targeted Therapies in Thyroid Cancer

November 17th 2015, 2:28am

Article

Nexavar and Lenvima have significantly altered the treatment paradigm for patients with advanced RAI-refractory differentiated thyroid cancer, with combination strategies hoping to further build upon this success.

Bethany Andrews Rhoten on How Patients Can Cope With Body Image Issues

September 30th 2015, 12:33am

Article

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses how patients with cancer can cope with body image issues.

Bethany Andrews Rhoten on Body Image Issues Among Patients With Head and Neck Cancer

September 29th 2015, 11:35pm

Article

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body images among patients and survivors of head and neck cancer.

Higher Risk of Thyroid Cancer Among Those With Breast Cancer History

March 11th 2015, 10:36pm

Article

According to a recent analysis of a large national database, patients with a history of breast cancer have a higher risk of developing thyroid cancer than the general population, particularly if they receive adjuvant radiation therapy.

Lenvima Approved to Treat Differentiated Thyroid Cancer

February 13th 2015, 10:10pm

Article

The FDA has granted approval to Lenvima (lenvatinib) as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), based on findings from the phase 3 SELECT trial.

Lenvatinib Approval for Thyroid Cancer 'Likely" as FDA Decision Date Nears

February 12th 2015, 9:19pm

Article

With a deadline of April 14, the FDA will soon make its final approval decision on lenvatinib as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).

Several Cancer Therapies Up for FDA Review in 2015

January 13th 2015, 10:48pm

Article

The Food and Drug Administration's calendar for making decisions on new cancer drugs and indications is taking shape for 2015, and the clock is ticking on at least 13 applications for novel agents and new therapeutic settings for existing drugs.

Pipeline

March 14th 2013, 9:00am

Article

The latest in cancer prevention, diagnosis & treatment.